News

Novartis AG said Sunday it is voluntarily recalling some over-the-counter products in the U.S., including its Excedrin headache pills and NoDoz medication, because they may contain broken or stray tablets from other products. The...

CanBas Co, a clinical-stage biopharmaceutical company, has received orphan drug designation fro the United States Food and Drug Administration (FDA) for it's CBP501 "for use in combination with cisplatin and pemetrexed for treatment of patients with mesothelioma. ...

  Acella Pharmaceuticals, LLC,  a company that develops, markets, sells and distributes a broad portfolio of non-branded pharmaceutical and other products, acquires a leading US prenatal brand, Prenate family of trademarks and other associated intellectual property. ...

For the sixth consecutive year, Eli Lilly and Company has received a 100 percent rating on the Human Rights Campaign (HRC) Corporate Equality Index (CEI) for lesbian, gay, bisexual and transgender (LGBT) equality in the workplace. ...

Takeda Pharmaceutical Company Limited announced that at the request of the European Commission (EC), the European Medicines Agency (EMA)’s Committee for Medical Products for Human Use (CHMP) has clarified the label changes for pioglitazone-containing medicines recommended in July of...

Amylin Pharmaceuticals, Inc., and Eli Lilly and Company announced that the U.S. Food and Drug Administration (FDA) has approved a new use for BYETTA® (exenatide) injection. BYETTA is now approved as an add-on therapy to insulin glargine, with...

Vertex Pharmaceuticals Incorporated announced the submission of a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for KALYDECO™ (VX-770, ivacaftor), a medicine in development that targets the defective protein that causes cystic fibrosis (CF)....